Aetna Provides Coverage for VeriStrat NSCLC Test
The blood-based proteomic test for patients with non-small cell lung cancer is now covered by three major national payers for a total of over 160 million covered lives.
Read More
Search Results for: lung cancer
NGS Service Offers Competitive Price Point for Cancer Testing
With a turnaround time of less than 7 days per reportable result, a next-generation sequencing service will perform molecular panel testing for invasive colon cancer for under $1,000.
Read More
Targeted Liquid Biopsy Mutation Test for Advanced Lung Cancer Launched
The GeneStrat test by Biodesix reveals actionable NSCLC mutations, returning results within 72 hours.
Read MoreCapnia Awarded NIH Grant to Develop Sickle Cell Anemia Screening in Developing Countries
Phase I SBIR grant for sickle cell disease research supported by scientific data recently published in Pediatric Blood & Cancer.
Read MoreFDA Grants PMA for Colorectal Cancer Mutation Test
A new molecular PCR test identifies KRAS mutations to aid in determining therapy for metastatic colorectal cancer.
Read More